Purification of hepatocyte comitogenic factor in plasma membrane and its action site (s) in hepatocyte proliferation.

质膜中肝细胞有丝分裂因子的纯化及其在肝细胞增殖中的作用位点。

基本信息

  • 批准号:
    04454240
  • 负责人:
  • 金额:
    $ 4.42万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1992
  • 资助国家:
    日本
  • 起止时间:
    1992 至 1993
  • 项目状态:
    已结题

项目摘要

Our previous observations show that rat plasma membrane has the ability to enhance induction of DNA synthesis by hepatocyte growth factors in cultured rat hepatocytes. The present study was attempted to purify this comitogenic factor from plasma membrane of rat hepatocytes and find its action sites. The following results have been so far obtained.1.PurificationThe comitogenic activity was extracted by collagenase digestion of the plasma membrane of rat hepatocytes partially purified according to the method of Hubbard et al., but the yield was too small to use for further purification by electrophoresis and column preparations. Although the yield was increased to 50% of the original activity by extraction with acetone, n-butanol or CHAPS,most of the activity was lost after column preparations with ion exchange resins. Antiserum against such extracts made using rabbits inhibited DNA synthesis by cultured rat hepatocytes, but immunoblot analysis revealed a lot of bands in the antiserum. To obtain hybridoma for a monoclonal antibody against the factor has not yet been successful.2.Action site(s)The plasma membrane increased concentrations of putrescine, an essential polyamine for hepatocyte proliferation, in cultured rat hapatocytes, while it abolished completely the decrease in DNA synthesis by the hepatocytes induced by ddition of TGF beta. When rats underwent 70% hepatectomy, the comitogenic activity in the liver was gradually decreased after 6 hr and disappeared at 24 hr, but recovered to normal levels at 31 hr. The comitogenic factor might act at the G1-phase of the cell cycle in association with putrescine production, and be inactivated or consumed during exerting its action.
我们以前的观察表明,大鼠质膜有能力提高诱导的DNA合成的肝细胞生长因子在培养的大鼠肝细胞。本研究试图从大鼠肝细胞质膜中分离纯化该共促因子,并寻找其作用部位。目前已获得以下结果:1.纯化通过胶原酶消化部分纯化的大鼠肝细胞的质膜来提取共有丝分裂活性,根据Hubbard等人的方法,但产量太小,不能用于通过电泳和柱制备的进一步纯化。虽然通过用丙酮、正丁醇或CHAPS萃取,产率增加到原始活性的50%,但用离子交换树脂柱制备后,大部分活性丧失。用兔制备的抗血清抑制培养的大鼠肝细胞的DNA合成,但免疫印迹分析显示抗血清中有许多条带。2.作用部位:细胞质膜能增加肝细胞增殖所必需的多胺腐胺的浓度,同时能完全消除TGF β诱导的肝细胞DNA合成的下降。当大鼠行70%肝切除术时,肝内共生因子活性在6小时后逐渐降低,24小时消失,31小时恢复正常,共生因子可能作用于细胞周期的G1期,与腐胺的产生有关,在发挥作用过程中被灭活或消耗。

项目成果

期刊论文数量(56)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
富谷智明ら: "Serum Hepatocyte Growth Factor Levels in Hepatectomized and Non-hepatectomized Surgical Patients." Gastroenterology. 103. 1621-1624 (1992)
Tomoaki Tomiya 等人:“肝切除和非肝切除手术患者的血清肝细胞生长因子水平。胃肠病学”103。1621-1624 (1992)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nagoshi S: "Stimulation of Putrescine Produaction by Epiderinal Growth Factor in Rat hiver after Partial Hepntectomy" Hepatology. 14. 901-905 (1991)
Nagoshi S:“部分肝切除术后大鼠冬眠中表皮生长因子对腐胺的刺激”肝病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
藤原 研司: "Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats." Hepatology. 18. 1443-1449 (1993)
Kenji Fujiwara:“外源性人肝细胞生长因子对正常和部分肝切除大鼠的肝脏生长的刺激”,18. 1443-1449 (1993)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
藤原 研司: "肝再生" Mebio. 11. 27-31 (199)
藤原健二:“肝脏再生”Mebio 11. 27-31 (199)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masaki N: "Hipatocyte Membrane Stabilizationly Prostag Candin E_1 and E_2 in Favorable Effects on Rat hiver Ingury" Gastroenterology. 102. 572-576 (1992)
Masaki N:“肝细胞膜稳定前列腺癌 Candin E_1 和 E_2 对大鼠 hiver Ingury 的有利影响”胃肠病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FUJIWARA Kenji其他文献

FUJIWARA Kenji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FUJIWARA Kenji', 18)}}的其他基金

Suppression of Pancreatic cancer neural invasion by regulation of Axon guidance molecule
调控Axon引导分子抑制胰腺癌神经侵袭
  • 批准号:
    20K22817
  • 财政年份:
    2020
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
NQR Study of Superconducting Mechanism mediated by Valence Fluctuations
价态涨落介导的超导机制的NQR研究
  • 批准号:
    21540338
  • 财政年份:
    2009
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetic Polymorphisms in Promoter Regions of Osteopontin Gene as Host Factors to Determine Th1 Immune Reactions against Hepatitis Virus.
骨桥蛋白基因启动子区的遗传多态性作为宿主因素确定针对肝炎病毒的 Th1 免疫反应。
  • 批准号:
    14370191
  • 财政年份:
    2002
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study on Strategies for Non-Heart Beating Liver
肝脏无心跳治疗策略研究
  • 批准号:
    11470137
  • 财政年份:
    1999
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
New devices in anticoagulant therapy for massive hepatic necrosis through sinusoidal fibrin deposition
通过肝窦纤维蛋白沉积抗凝治疗大面积肝坏死的新装置
  • 批准号:
    06454258
  • 财政年份:
    1994
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Factors Associated with Insufficient Liver Regeneration in Fulminant Hepatic Failure
暴发性肝衰竭中肝脏再生不足的相关因素
  • 批准号:
    01480223
  • 财政年份:
    1989
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
ROLE OF SUPEROXIDE FROM MACROPHAGES IN HEPATIC FIBROSIS
巨噬细胞超氧化物在肝纤维化中的作用
  • 批准号:
    60480207
  • 财政年份:
    1985
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Targeting Autocrine Hepatocyte Growth Factor (HGF) Production as a Therapeutic Modality in Acute Myeloid Leukemia (AML)
靶向自分泌肝细胞生长因子 (HGF) 的产生作为急性髓系白血病 (AML) 的治疗方式
  • 批准号:
    10589002
  • 财政年份:
    2022
  • 资助金额:
    $ 4.42万
  • 项目类别:
Hepatocyte Growth Factor Signaling and Airspace Maintenance
肝细胞生长因子信号传导和空域维护
  • 批准号:
    10316452
  • 财政年份:
    2021
  • 资助金额:
    $ 4.42万
  • 项目类别:
Hepatocyte Growth Factor Signaling and Airspace Maintenance
肝细胞生长因子信号传导和空域维护
  • 批准号:
    10470865
  • 财政年份:
    2021
  • 资助金额:
    $ 4.42万
  • 项目类别:
Hepatocyte Growth Factor Signaling and Airspace Maintenance
肝细胞生长因子信号传导和空域维护
  • 批准号:
    10626872
  • 财政年份:
    2021
  • 资助金额:
    $ 4.42万
  • 项目类别:
A Hepatocyte Growth Factor In A Spinal Cord Ischemia
脊髓缺血中的肝细胞生长因子
  • 批准号:
    18K16402
  • 财政年份:
    2018
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Protective effects of hepatocyte growth factor during ex vivo lung perfusion on ischemia-reperfusion injury in lung transplantation
离体肺灌注过程中肝细胞生长因子对肺移植缺血再灌注损伤的保护作用
  • 批准号:
    18K16416
  • 财政年份:
    2018
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Immune Microenvironments and Hepatocyte Growth Factor Signaling Interactions in Breast Cancer Disparities
乳腺癌差异中的免疫微环境和肝细胞生长因子信号传导相互作用
  • 批准号:
    10708080
  • 财政年份:
    2017
  • 资助金额:
    $ 4.42万
  • 项目类别:
Immune Microenvironments and Hepatocyte Growth Factor Signaling Interactions in Breast Cancer Disparities
乳腺癌差异中的免疫微环境和肝细胞生长因子信号传导相互作用
  • 批准号:
    10556581
  • 财政年份:
    2017
  • 资助金额:
    $ 4.42万
  • 项目类别:
Hepatocyte growth factor to Improve Functioning in PAD: the HI-PAD Study
肝细胞生长因子可改善 PAD 功能:HI-PAD 研究
  • 批准号:
    9373019
  • 财政年份:
    2017
  • 资助金额:
    $ 4.42万
  • 项目类别:
Establishment of regenerative therapy for dogs using delivery system of hepatocyte growth factor secreted from novel canine mesenchymal stem cells
利用新型犬间充质干细胞分泌的肝细胞生长因子输送系统建立犬再生疗法
  • 批准号:
    16H05037
  • 财政年份:
    2016
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了